Literature DB >> 17057709

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Neeta S Roy1, Carine Cleren, Shashi K Singh, Lichuan Yang, M Flint Beal, Steven A Goldman.   

Abstract

To direct human embryonic stem (HES) cells to a dopaminergic neuronal fate, we cocultured HES cells that were exposed to both sonic hedgehog and fibroblast growth factor 8 with telomerase-immortalized human fetal midbrain astrocytes. These astrocytes substantially potentiated dopaminergic neurogenesis by both WA09 and WA01 HES cells, biasing them to the A9 nigrostriatal phenotype. When transplanted into the neostriata of 6-hydroxydopamine-lesioned parkinsonian rats, the dopaminergic implants yielded a significant, substantial and long-lasting restitution of motor function. However, although rich in donor-derived tyrosine hydroxylase-expressing neurons, the grafts exhibited expanding cores of undifferentiated mitotic neuroepithelial cells, which can be tumorigenic. These results show the utility of recreating the cellular environment of the developing human midbrain while driving dopaminergic neurogenesis from HES cells, and they demonstrate the potential of the resultant cells to mediate substantial functional recovery in a model of Parkinson disease. Yet these data also mandate caution in the clinical application of HES cell-derived grafts, given their potential for phenotypic instability and undifferentiated expansion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057709     DOI: 10.1038/nm1495

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  291 in total

1.  Dopaminergic neurons for Parkinson's therapy.

Authors:  Olle Lindvall
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

Review 2.  Induced neuronal cells: how to make and define a neuron.

Authors:  Nan Yang; Yi Han Ng; Zhiping P Pang; Thomas C Südhof; Marius Wernig
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

3.  Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons.

Authors:  Dylan A McCreedy; Cara R Rieger; David I Gottlieb; Shelly E Sakiyama-Elbert
Journal:  Stem Cell Res       Date:  2011-12-13       Impact factor: 2.020

Review 4.  Neural stem cells: mechanisms and modeling.

Authors:  Jun Yao; Yangling Mu; Fred H Gage
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 5.  Modulation of dopaminergic neuronal differentiation from sympathoadrenal progenitors.

Authors:  Vladimir Vukicevic; Maria F Rubin de Celis; Gabriela Diaz-Valencia; Stefan R Bornstein; Monika Ehrhart-Bornstein
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

6.  Clonal neural stem cells from human embryonic stem cell colonies.

Authors:  Radha Chaddah; Margot Arntfield; Susan Runciman; Laura Clarke; Derek van der Kooy
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

7.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Authors:  Bao-Yang Hu; Jason P Weick; Junying Yu; Li-Xiang Ma; Xiao-Qing Zhang; James A Thomson; Su-Chun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 8.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 9.  Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Authors:  Aaron B Bradford; Patrick M McNutt
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

10.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.